Noticias de CAPR_US

Mercado

Noticias del mercado

Últimas noticias sobre CAPR_US — 926 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CAPR_US 926 resultados
21/08/2026 CAPR_US — FinancialContent
Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm Before Lead Plaintiff Deadline on September 28, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

21/08/2026 CAPR_US — TMX Newsfile
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 21, 2026) - Kahn Swick & Foti, LLC ("KSF")...

21/08/2026 CAPR_US — FinancialContent
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 21, 2026) - Kahn Swick & Foti, LLC ("KSF")...

21/08/2026 CAPR_US — PR Newswire
Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

/PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP anuncia que los inversores con pérdidas tienen la oportunidad de liderar la demanda colectiva por fraude de valores...

21/08/2026 CAPR_US — The Globe and Mail
Kaplan Fox Reminds Investors of a Securities Class Action Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) – Deadline is September 28, 2026

Detailed price information for Capricor Therap (CAPR-Q) from The Globe and Mail including charting and trades.

21/08/2026 CAPR_US — finance.biggo.com
Activist Investor Kaos Capital Demands Board Overhaul at Capricor Ahead of FDA Decision on DMD Therapy

El inversionista activista Kaos Capital exige cambios inmediatos en la junta directiva de Capricor Therapeutics antes de la fecha de acción de la FDA del 22 de agosto sobre deramiocel, un...

21/08/2026 CAPR_US — PR Newswire
INVESTOR DEADLINE: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Substantial Losses Have Opportunity to Lead Capricor Class Action Lawsuit Before September 28, 2026 Deadline

/PRNewswire/ -- El bufete de abogados Robbins Geller Rudman & Dowd LLP anuncia que los compradores o adquirentes de Capricor Therapeutics, Inc. (NASDAQ: CAPR)...

21/08/2026 CAPR_US — mykxlg.com ES ← EN
Los inversores de CAPR tienen la oportunidad de liderar la demanda por fraude de valores de Capricor Therapeutics, Inc. ante la ley SBS

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

21/08/2026 CAPR_US — FinancialContent
FinancialContent - INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR

ALERTA PARA INVERSORES: El bufete de abogados Pomerantz recuerda a los inversores con pérdidas en su inversión en Capricor Therapeutics, Inc. sobre la demanda colectiva y los próximos plazos – CAPR

21/08/2026 CAPR_US — TechStock² ES ← EN
Las acciones de Capricor enfrentan un caso de fraude de valores mientras la revisión de la FDA permanece abierta

Las acciones de Capricor se enfrentan a un caso de fraude de valores mientras la revisión de la FDA permanece abierta - TechStock²

Página 12 de 47